Related Experiment Videos
Different genetic features associated with colon and rectal carcinogenesis.
Milo Frattini1, Debora Balestra, Simona Suardi
1Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, and Federazione Italiana Ricerca Cancro, Institute of Molecular Oncology, Milan, Italy.
Summary
Sporadic colorectal cancers (SCRCs) exhibit distinct molecular pathways, differing between colon and rectal tumors. Identifying these differences aids in improved diagnosis and targeted treatments for colorectal cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The classification of colon and rectal cancers as a single entity or two distinct ones remains debated.
- Understanding the heterogeneity in sporadic colorectal cancers (SCRCs) and molecular differences between colon and rectal tumors is crucial.
Purpose of the Study:
- To investigate the molecular and biological differences between colon and rectal cancers.
- To elucidate the pathogenetic pathways of SCRCs.
Main Methods:
- Analysis of somatic mutations in APC, K-ras, and TP53 genes in SCRCs.
- Assessment of loss-of-heterozygosity on chromosome 18.
- Evaluation of microsatellite instability (MSI) and beta-catenin overexpression.
Main Results:
- Eleven SCRCs displayed microsatellite instability (MSI+).
- APC mutation frequency was lower in MSI+ SCRCs compared to microsatellite stable (MSS) SCRCs.
- All MSS SCRCs showed beta-catenin overexpression, indicating APC-beta-catenin pathway inactivation.
Conclusions:
- The APC-beta-catenin pathway is an early event in MSS SCRC development.
- Two main pathways for SCRCs exist: one K-ras dependent and another K-ras independent.
- Significant molecular differences were observed between colon and rectal tumors in MSS SCRCs, including mutation frequency and specific gene alterations, suggesting distinct tumor behaviors and potential therapeutic targets.